Andrew Staron

发表

Assessment of minimal residual disease using multiparametric flow cytometry in patients with AL amyloidosis.

E. Burks, S. Sarosiek, V. Sanchorawala, 2020, Blood advances.

A pharmacist’s review of the treatment of systemic light chain amyloidosis

V. Sanchorawala, Andrew Staron, David M. Hughes, 2020, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Prevalence of plasma cell and lymphoproliferative disorders among blood relatives of patients with light chain amyloidosis

V. Sanchorawala, Andrew Staron, Karina Verma, 2022, British journal of haematology.

A new era of amyloidosis: the trends at a major US referral centre

L. Connors, V. Sanchorawala, Andrew Staron, 2019, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Predictors of hematologic response and survival with stem cell transplantation in AL amyloidosis: A 25‐year longitudinal study

J. Berk, V. Sanchorawala, Andrew Staron, 2022, American journal of hematology.

Orthotopic heart transplant rejection in association with immunomodulatory therapy for AL amyloidosis: A case series and review of the literature

G. Lewis, V. Sanchorawala, Andrew Staron, 2019, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Marked progress in AL amyloidosis survival: a 40-year longitudinal natural history study

G. Doros, L. Connors, V. Sanchorawala, 2021, Blood Cancer Journal.

Light chain amyloidosis associated with Waldenström macroglobulinemia: treatment and survival outcomes

V. Sanchorawala, Andrew Staron, J. Sloan, 2022, Haematologica.

Race/ethnicity in systemic AL amyloidosis: perspectives on disease and outcome disparities

G. Doros, L. Connors, V. Sanchorawala, 2020, Blood Cancer Journal.

Systemic AL amyloidosis with an undetectable plasma cell dyscrasia: A zebra without stripes

D. Murray, V. Sanchorawala, Andrew Staron, 2019, American journal of hematology.

Factors affecting the accuracy of amyloidosis identification and referral to a specialty centre

V. Sanchorawala, Andrew Staron, F. Ruberg, 2023, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

Differences in the cytogenetic underpinnings of AL amyloidosis among African Americans and Caucasian Americans

G. Doros, V. Sanchorawala, Andrew Staron, 2022, Blood Cancer Journal.

Successful dasatinib therapy in newly diagnosed chronic myeloid leukemia in the setting of short bowel syndrome.

Andrew Staron, J. Sloan, David M. Hughes, 2023, Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners.

Non-producer multiple myeloma presenting with acute hyperammonemic encephalopathy: case report

V. Sanchorawala, Andrew Staron, Julie Li, 2023, Diagnostic Pathology.

Predictors of treatment response and survival outcomes in patients with advanced cardiac AL amyloidosis

V. Sanchorawala, Andrew Staron, F. Ruberg, 2023, Blood advances.